Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4303668 | 4029730 | F | 2 | 4303668-3 | 20030101 | 20040206 | 20040223 | EXP | 701234 | BIOGEN IDEC | 49 | YR | F | N | 130 | LBS | 20040220 | MD |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4303668 | 1004650063 | PS | AMEVIVE | 1 | INTRAMUSCULAR | 15 MG QW IM | D | D |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4303668 | 1004650063 | PSORIASIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4303668 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4303668 | ALANINE AMINOTRANSFERASE INCREASED |
| 4303668 | ASPARTATE AMINOTRANSFERASE INCREASED |
| 4303668 | CONDITION AGGRAVATED |
| 4303668 | GAMMA-GLUTAMYLTRANSFERASE INCREASED |
| 4303668 | HEPATIC STEATOSIS |
| 4303668 | HYPERLIPIDAEMIA |
| 4303668 | IATROGENIC INJURY |
| 4303668 | PRURITUS |
| 4303668 | PSORIASIS |
| 4303668 | THERMAL BURN |
| 4303668 | TREMOR |
| 4303668 | VOMITING |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4303668 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4303668 | 1004650063 | 20030506 | 20030101 |